Company Monitoring Page for AcelRx

latest headlines for company on cafepharma

AcelRx Pharmaceuticals completes divestment of DSUVIA to Alora Pharmaceuticals
Pharmaceutical Business Review
Thu, 04/6/23 - 11:31 am
Tags:
AcelRx, Dsuvia, Alora Pharmaceuticals
AcelRx to Buy Lowell Therapeutics; Kala Expands Pipeline with Combangio Acquisition
BioSpace
Tue, 11/16/21 - 10:37 pm
Tags:
AcelRx, Kala Pharmaceuticals, M&A, Lowell Therapeutics, Combangio
OPDP warns AcelRx over Dsuvia promotional materials
RAPS.org
Tue, 02/16/21 - 11:34 pm
Tags:
FDA, OPDP, Dsuvia, AcelRx, warning letter, opioids
As it happened: A bidding war for an antibiotic maker in a market that has ravaged its peers
Endpoints
Fri, 06/5/20 - 11:01 am
Tags:
antibiotics, M&A, Tetraphase, AcelRx, Melinta Therapeutics, La Jolla Pharmaceutical
A Covid-19 threat to business acquisitions
EP Vantage
Thu, 04/2/20 - 11:57 am
Tags:
COVID-19, M&A, AbbVie, Allergan, Arya Sciences, Immatics, AcelRx, Tetraphase, Gilead Sciences, Forty Seven, Thermo Fisher, Stryker, Wright Medical
Another antibiotic maker bites the dust, as Tetraphase is swallowed for cheap
Endpoints
Mon, 03/16/20 - 11:02 am
Tags:
antibiotics, Tetraphase, M&A, AcelRx
Sarepta, AcelRx Look to Infuse Some Cash into Their Pipelines
BioSpace
Sat, 11/10/18 - 12:00 pm
Tags:
Sarepta Therapeutics, AcelRx, stock offering
FDA to develop new framework for opioid analgesics following AcelRx approval
Drug Delivery Business News
Mon, 11/5/18 - 10:02 am
Tags:
FDA, opioids, Dsuvia, AcelRx
Despite criticism and concerns, FDA approves a new opioid 10 times more powerful than fentanyl
Stat
Fri, 11/2/18 - 07:51 pm
Tags:
FDA, opioids, Dsuvia, AcelRx
AcelRx shares fall as Sen. Markey calls on FDA to reject opioid painkiller
Drug Delivery Business News
Mon, 10/22/18 - 10:42 am
Tags:
AcelRx, Dsuvia, FDA, opioids
3 Biotechs Awaiting FDA Approval Decisions
Motley Fool
Tue, 10/16/18 - 11:52 am
Tags:
FDA, TherapeuticsMD, TX-001HR, AcelRx, Dsuvia, Loxo Oncology, larotrectinib
FDA panel votes in favor of AcelRx's pain candidate
BioCentury
Fri, 10/12/18 - 11:45 pm
Tags:
Dsuvia, ARX-04, FDA, AcelRx
AcelRx tackles acute pain with sublingual drug-delivery tech
Drug Delivery Business News
Fri, 06/8/18 - 10:49 am
Tags:
AcelRx, acute pain, drug delivery, sublingual treatments
FDA rejection blocks another AcelRx drug from US market
Biopharma Dive
Thu, 10/12/17 - 10:16 pm
Tags:
FDA, AcelRx, Dsuvia
In a new setback, FDA kicks back AcelRx’s application for pain med — shares tank again
Endpoints
Thu, 10/12/17 - 09:23 am
Tags:
FDA, AcelRx, Dsuvia, ARX-04, painkillers
Why AcelRx Pharmaceuticals Inc Jumped Higher Today
Motley Fool
Mon, 10/2/17 - 10:11 pm
Tags:
AcelRx, painkillers, Dsuvia, FDA
AcelRx’s pain relief drug-device combo succeeds in late-stage trial
Drug Delivery Business News
Tue, 08/1/17 - 10:52 pm
Tags:
AcelRx, Zalviso, devices, drug-device combos
5 Biotech Stocks With Major Catalysts in July
Motley Fool
Wed, 06/28/17 - 11:03 pm
Tags:
biotech, AcelRx, Zalviso, Alnylam, Patisiran, Dynavax, HEPLISAV-B, GSK, Benlysta, Puma Biotechnology, neratinib
AcelRx's opioid painkiller succeeds in key study
Yahoo/Reuters
Thu, 09/15/16 - 09:28 am
Tags:
AcelRx, opioids, painkillers, clinical trials
AcelRx Pharma's pain drug succeeds in late-stage study
Yahoo/Reuters
Wed, 09/9/15 - 10:40 am
Tags:
AcelRx, painkillers, ARX-04

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.